$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 15 16 17 18 19
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.33 | 83 | 3,181 | 5,653 | 5.7 K to 5.7 K (-1.45 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.30 | 574 | 21,984 | 5,736 | 6.3 K to 5.7 K (-9.10 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.25 | 136 | 5,202 | 6,310 | 6.4 K to 6.3 K (-2.11 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.24 | 748 | 28,604 | 6,446 | 7.2 K to 6.4 K (-10.40 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.23 | 38 | 1,453 | 7,194 | 7.2 K to 7.2 K (-0.53 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.20 | 90 | 3,438 | 7,232 | 7.3 K to 7.2 K (-1.23 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 38.18 | 5 | 191 | 7,322 | 7.3 K to 7.3 K (-0.07 %) |
Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 1,750 | 11,375 | 7,327 | 5.6 K to 7.3 K (+31.38 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | A | 38.61 | 7,500 | 289,575 | 7,500 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Grant | A | 0.00 | 809 | 0 | 22,890 | 22.1 K to 22.9 K (+3.66 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | A | 38.61 | 15,000 | 579,150 | 15,000 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Grant | A | 0.00 | 809 | 0 | 2,890 | 2.1 K to 2.9 K (+38.88 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Option Exercise | A | 38.61 | 15,000 | 579,150 | 15,000 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | MEHTA VIREN | Director | Grant | A | 0.00 | 1,619 | 0 | 36,152 | 34.5 K to 36.2 K (+4.69 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVERBERG WALTER | Director | Option Exercise | A | 38.61 | 7,500 | 289,575 | 7,500 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVERBERG WALTER | Director | Grant | A | 0.00 | 971 | 0 | 8,052 | 7.1 K to 8.1 K (+13.71 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 38.61 | 15,000 | 579,150 | 15,000 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 0.00 | 2,914 | 0 | 10,404 | 7.5 K to 10.4 K (+38.91 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | A | 38.61 | 10,000 | 386,100 | 10,000 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Grant | A | 0.00 | 1,000 | 0 | 5,577 | 4.6 K to 5.6 K (+21.85 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Option Exercise | A | 38.61 | 7,500 | 289,575 | 7,500 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | GEE EDWIN A | Director | Grant | A | 0.00 | 809 | 0 | 3,555 | 2.7 K to 3.6 K (+29.46 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | A | 38.61 | 7,500 | 289,575 | 7,500 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Grant | A | 0.00 | 971 | 0 | 23,868 | 22.9 K to 23.9 K (+4.24 %) |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Director | Option Exercise | A | 38.61 | 7,500 | 289,575 | 7,500 | |
Mar 19 2004 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Director | Grant | A | 0.00 | 1,166 | 0 | 3,197 | 2 K to 3.2 K (+57.41 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Human Resources ... | Option Exercise | M | 21.55 | 4,203 | 90,575 | 6,997 | |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Human Resources ... | Sell | S | 43.00 | 4,203 | 180,729 | 0 | 4.2 K to 0 (-100.00 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Human Resources ... | Buy | M | 21.55 | 4,203 | 90,575 | 4,203 | 0 to 4.2 K |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 1,250 | 8,125 | 41,750 | |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 40.00 | 1,250 | 50,000 | 4,577 | 5.8 K to 4.6 K (-21.45 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 1,250 | 8,125 | 5,827 | 4.6 K to 5.8 K (+27.31 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Option Exercise | M | 9.25 | 10,000 | 92,500 | 0 | |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 40.00 | 5,000 | 200,000 | 22,897 | 27.9 K to 22.9 K (-17.92 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 42.50 | 5,000 | 212,500 | 27,897 | 32.9 K to 27.9 K (-15.20 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Sell | S | 37.50 | 5,000 | 187,500 | 32,897 | 37.9 K to 32.9 K (-13.19 %) |
Mar 05 2004 | OSIP | OSI PHARMACEUTICAL ... | BROWNE G MORGAN | Director | Buy | M | 9.25 | 10,000 | 92,500 | 37,897 | 27.9 K to 37.9 K (+35.85 %) |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | FRENCH JOHN H II | Director | Option Exercise | M | 3.63 | 2,497 | 9,052 | 0 | |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | FRENCH JOHN H II | Director | Buy | M | 3.63 | 2,497 | 9,052 | 2,497 | 0 to 2.5 K |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 1,000 | 21,550 | 15,760 | |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 35.00 | 1,000 | 35,000 | 0 | 1,000 to 0 (-100.00 %) |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 1,000 | 21,550 | 1,000 | 0 to 1,000 |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 26,316 | |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 35.00 | 798 | 27,930 | 4,255 | 5.1 K to 4.3 K (-15.79 %) |
Mar 04 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 44,200 | |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.46 | 100 | 3,246 | 2,081 | 2.2 K to 2.1 K (-4.59 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.43 | 100 | 3,243 | 2,181 | 2.3 K to 2.2 K (-4.38 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.45 | 100 | 3,245 | 2,281 | 2.4 K to 2.3 K (-4.20 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.55 | 100 | 3,255 | 2,381 | 2.5 K to 2.4 K (-4.03 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.42 | 100 | 3,242 | 2,481 | 2.6 K to 2.5 K (-3.87 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.41 | 372 | 12,057 | 2,581 | 3 K to 2.6 K (-12.60 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.53 | 200 | 6,506 | 2,953 | 3.2 K to 3 K (-6.34 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 32.50 | 378 | 12,285 | 3,153 | 3.5 K to 3.2 K (-10.71 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 3,531 | 2.1 K to 3.5 K (+69.68 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 1,750 | 11,375 | 43,000 | |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 32.70 | 1,750 | 57,225 | 4,577 | 6.3 K to 4.6 K (-27.66 %) |
Mar 01 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 1,750 | 11,375 | 6,327 | 4.6 K to 6.3 K (+38.23 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 1,000 | 21,550 | 16,760 | |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 35.00 | 1,000 | 35,000 | 0 | 1,000 to 0 (-100.00 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 1,000 | 21,550 | 1,000 | 0 to 1,000 |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Option Exercise | M | 16.81 | 1,450 | 24,379 | 45,650 | |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Sell | S | 34.73 | 1,450 | 50,359 | 2,081 | 3.5 K to 2.1 K (-41.06 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | RICHMOND MARK | Director | Buy | M | 16.81 | 1,450 | 24,379 | 3,531 | 2.1 K to 3.5 K (+69.68 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 27,114 | |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 35.00 | 798 | 27,930 | 4,255 | 5.1 K to 4.3 K (-15.79 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 1,750 | 11,375 | 44,750 | |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 34.73 | 1,750 | 60,778 | 4,577 | 6.3 K to 4.6 K (-27.66 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 1,750 | 11,375 | 6,327 | 4.6 K to 6.3 K (+38.23 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | FRENCH JOHN H II | Director | Option Exercise | M | 6.50 | 2,000 | 13,000 | 1,303 | |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | FRENCH JOHN H II | Director | Sell | S | 35.00 | 2,000 | 70,000 | 21,997 | 24 K to 22 K (-8.33 %) |
Feb 03 2004 | OSIP | OSI PHARMACEUTICAL ... | FRENCH JOHN H II | Director | Buy | M | 6.50 | 2,000 | 13,000 | 23,997 | 22 K to 24 K (+9.09 %) |